Literature DB >> 33982751

Letter to the editor concerning Kuksis et al.

Naomi R M Schwartz1, Ronit R Dalmat2.   

Abstract

Entities:  

Year:  2021        PMID： 33982751      PMCID： PMC8328011          DOI： 10.1093/neuonc/noab050

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  4 in total

1.  A Prospective Randomised Phase III Clinical Trial Testing the Role of Prophylactic Cranial Radiotherapy in Patients Treated with Trastuzumab for Metastatic Breast Cancer - Anglo Celtic VII.

Authors:  P Canney; E Murray; J Dixon-Hughes; L-A Lewsley; J Paul
Journal:  Clin Oncol (R Coll Radiol)       Date:  2015-05-11       Impact factor: 4.126

2.  CEREBEL (EGF111438): A Phase III, Randomized, Open-Label Study of Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer.

Authors:  Xavier Pivot; Alexey Manikhas; Bogdan Żurawski; Ewa Chmielowska; Boguslawa Karaszewska; Rozenn Allerton; Stephen Chan; Alessandra Fabi; Paolo Bidoli; Stefania Gori; Eva Ciruelos; Magdolna Dank; Lajos Hornyak; Sara Margolin; Arnd Nusch; Roma Parikh; Fareha Nagi; Michelle DeSilvio; Sergio Santillana; Ramona F Swaby; Vladimir Semiglazov
Journal:  J Clin Oncol       Date:  2015-01-20       Impact factor: 44.544

3.  Neratinib Plus Paclitaxel vs Trastuzumab Plus Paclitaxel in Previously Untreated Metastatic ERBB2-Positive Breast Cancer: The NEfERT-T Randomized Clinical Trial.

Authors:  Ahmad Awada; Ramon Colomer; Kenichi Inoue; Igor Bondarenko; Rajendra A Badwe; Georgia Demetriou; Soo-Chin Lee; Ajay O Mehta; Sung-Bae Kim; Thomas Bachelot; Chanchal Goswami; Suryanarayan Deo; Ron Bose; Alvin Wong; Feng Xu; Bin Yao; Richard Bryce; Lisa A Carey
Journal:  JAMA Oncol       Date:  2016-12-01       Impact factor: 31.777

4.  The incidence of brain metastases among patients with metastatic breast cancer: a systematic review and meta-analysis.

Authors:  Markus Kuksis; Yizhuo Gao; William Tran; Christianne Hoey; Alex Kiss; Adam S Komorowski; Aman J Dhaliwal; Arjun Sahgal; Sunit Das; Kelvin K Chan; Katarzyna J Jerzak
Journal:  Neuro Oncol       Date:  2021-06-01       Impact factor: 12.300
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.